Banco Santander Chile (BSANTANDER)
Chilean Stock Exchange · Chile · prices in CLP · close of 22 Oct 2026
Key indicators
| Last close | CLP 79.20 |
|---|---|
| 52-week range | 65.69 – 84.40 |
| Return, 1 month / 3 months | −4.6% / −0.8% |
| Return, 1 year / 3 years | +24.8% / +126.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 23.9% |
| Worst drawdown (1 year) | -12.6% |
| Average daily value traded | 7,918.11M CLP |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander Chile is a bank based in Santiago that serves individuals and businesses across Chile. It takes deposits and provides current accounts, savings products, mortgages, consumer loans and credit cards to retail customers, while companies and small businesses use its commercial lending, cash management and trade services. The bank also offers investment and insurance products through its branch network and digital channels, and it is part of the wider Santander banking group.
On this site Banco Santander Chile appears as a stock on the Chilean Stock Exchange (Chile), code BSANTANDER, with prices in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander Chile (BSANTANDER) trades on the Chilean Stock Exchange in Chile. It last closed at CLP 79.20 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 24 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.8% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Chilean Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.5% | ||
| From 52-week high | -5.6% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | 11.0% | ||
| 12-month return, skipping the last month | 30.7% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.6% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 7,918.11M CLP | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | −4.6% |
| 3 months | −0.8% |
| 6 months | +11.0% |
| 1 year | +24.8% |
| 3 years | +126.0% |
| 5 years | +181.2% |
Signals
| 50-day / 200-day average | 81.01 / 75.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | CLP 3.3534 |
| 24 Apr 2025 | CLP 3.1857 |
| 19 Apr 2024 | CLP 1.8439 |
| 21 Apr 2023 | CLP 2.5747 |
| 25 Apr 2022 | CLP 2.4674 |
| 26 Apr 2021 | CLP 1.6475 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Chilean Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.